Biochemistry
-
One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening
This article has 12 authors:Reviewed by ScreenIT
-
An Antioxidant Enzyme Therapeutic for COVID‐19
This article has 29 authors:Reviewed by ScreenIT
-
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2
This article has 35 authors:Reviewed by ScreenIT
-
Preferential recognition and antagonism of SARS-CoV-2 spike glycoprotein binding to 3- O -sulfated heparan sulfate
This article has 7 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
This article has 18 authors:Reviewed by ScreenIT
-
Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors
This article has 20 authors:Reviewed by ScreenIT
-
SARS-CoV-2 proteins bind heme and hemoglobin
This article has 15 authors:Reviewed by ScreenIT
-
Efficiency Improvements and Discovery of New Substrates for a SARS-CoV-2 Main Protease FRET Assay
This article has 5 authors:Reviewed by ScreenIT
-
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase
This article has 12 authors:Reviewed by ScreenIT
-
Production of a Highly Immunogenic Antigen from SARS-CoV-2 by Covalent Coupling of the Receptor Binding Domain of Spike Protein to a Multimeric Carrier
This article has 28 authors:Reviewed by ScreenIT